Better Space Stock: Rocket Lab vs. Firefly Aerospace

Rocket Lab reported $403M in space systems revenue and $199M in launch revenue for 2025, with a net loss of ~$200M, 21 Electron launches in 2025 and 30+ new launch contracts last year (P/S ~60). Firefly generated $160M revenue in 2025, lost nearly $300M, raised $868M in its public raise last year and successfully launched its Alpha in April (P/S ~32). The article favors Rocket Lab as the better buy due to a stronger commercial launch track record despite a higher valuation, but notes both stocks look expensive and the theme is speculative ahead of the anticipated SpaceX IPO.

Analysis

The market is pricing a binary, technology-adoption story into small-launch equities: investors anchor on future cadence and addressable markets while largely ignoring cash-burn and contract conversion timing. That creates outsized sensitivity to two variables — monthly launch cadence (which drives margin and perception) and the timing of defense/large-commercial contract awards — so valuation moves will be event-driven rather than steady accumulation of recurring cash flow.

Second-order winners are suppliers and services with long lead times (composites, avionics, propulsion subvendors) and defense integrators that can wrap launch + payload into one program; losers are pure-play launch providers without sticky systems revenue or government IDIQ footprints, because pricing competition and launch reliability become primary margin levers. The impending SpaceX IPO is a force-multiplier for sector sentiment: a strong IPO can re-rate comps higher but also concentrates commercial demand toward the lowest-cost provider, compressing pricing power for mid-tier launchers.

Key risks are capital markets (equity/dilution) and program reliability: a single high-profile failure or a quarter of missed backlog conversion can easily erase the implied multi-year upside baked into current prices. Time horizon matters — tradeable catalysts cluster in the next 6–24 months (launch windows, contract awards, and SpaceX IPO cadence) while profitability and margin expansion are 2–5 year plays dependent on scale and defense wins.

Key Decisions for Investors

• Long RKLB via 18–24 month call LEAPS (buy calls or call spreads) sized 1–2% NAV: asymmetric upside to capture re-rating if cadence and government awards continue, with max loss limited to premium. Place mental stop/hedge: if a major launch failure occurs or a dilutive financing >10% is announced, reduce or hedge position.
• Pair trade — long RKLB / short FLY, equal notional (net 0.5–1% NAV): expresses selection within the sector to isolate execution risk. Target R/R ~2:1 over 6–12 months; trim the short if FLY announces a credible multi-year government contract (puts pressure on pair outcome).
• Volatility harvest around near-term launch windows: sell near-term (30–60 day) covered calls or put spreads on RKLB to monetize elevated IV while keeping a directional exposure via LEAPS. Keep strike selection 10–20% above spot to balance premium capture with upside participation.
• Contrarian micro-bet on FLY via long-dated deep-OTM call calendar (small sizing, <0.5% NAV): binary hedge for M&A or large defense contract upside. Limit downside to option premium — this is a high-probability small loss versus low-probability large payoff.
• Maintain dry powder and alerts: set watch for SpaceX IPO pricing and the next major government award cycle (6–12 month window). Prioritize moves within 48–72 hours of award announcements; expect 25–50% intra-week volatility on headline outcomes and size trades accordingly.